Announcements Trials
Browse Landscape

Phase

Phase 2 90Phase 1 56Phase 1/2 42Phase 3 16Phase NA 12Phase 2/3 7Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 12Terminated 9Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 310INDUSTRY 64OTHER_GOV 6NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

pirtobrutinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recruiting × NIH × Clear all
NCT07428707 2026-06-04

Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Recruiting
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡